Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
07 5월 2024 - 9:30PM
Business Wire
Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering
neuroscience to deliver groundbreaking therapies for individuals
affected by psychiatric and neurological disorders, today announced
that company management will present and host one-on-one meetings
during the 2024 RBC Capital Markets Global Healthcare Conference
taking place May 14 and 15, 2024 in New York City.
2024 RBC Capital Markets Global Healthcare Conference
- Shawn Singh, Chief Executive Officer, will participate in a
fireside chat on Wednesday, May 15 at 4:05 p.m. Eastern Time.
A webcast will be accessible through the “Events” page in the
“Investors” section of the Company’s website at www.Vistagen.com.
Investors interested in arranging a one-on-one meeting during the
conference should contact their RBC representative.
About Vistagen
Vistagen (Nasdaq: VTGN) is a biopharmaceutical company
pioneering neuroscience to deliver groundbreaking therapies for
individuals affected by psychiatric and neurological disorders.
Five of Vistagen’s clinical-stage neuroscience pipeline candidates
belong to a new class of drugs known as pherines, which are
investigational neuroactive nasal sprays with innovative proposed
mechanisms of action that activate chemosensory neurons in the
nasal passages to impact fundamental neurocircuitry in the brain
without the need for systemic absorption or binding to receptors in
the brain. Vistagen’s sixth investigational candidate is an oral
prodrug with potential to modulate NMDA receptor activity. At
Vistagen, we are passionate about delivering differentiated
treatments that set new standards of care for people living with
anxiety, depression, and other neurological disorders. Connect at
www.Vistagen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507196395/en/
Investors: Mark A. McPartland Vistagen Therapeutics
markmcp@vistagen.com
Media: Caren Scannell Vistagen Therapeutics
cscannell@vistagen.com
Vistagen Therapeutics (NASDAQ:VTGN)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Vistagen Therapeutics (NASDAQ:VTGN)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024